Zou, Guangyong

Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care

DeGorter, M. K., Tirona, R. G., Schwarz, U. I., Choi, Y.-H., Dresser, G. K., Suskin, N., Myers, K., Zou, G., Iwuchukwu, O., Wei, W.-Q., et al. (2013) · Circulation: Cardiovascular Genetics

Pharmacogenetics and Drug MetabolismLipoproteins and Cardiovascular Health

Cited by 195

Conservative management in hypertriglyceridemia-associated pancreatitis

Berberich, A. J., Ziada, A., Zou, G. Y., & Hegele, R. A. (2019) · Journal of Internal Medicine

Pancreatitis Pathology and TreatmentGallbladder and Bile Duct Disorders

Cited by 67

Severe (level 3) hypoglycaemia occurrence in a real‐world cohort of adults with type 1 or 2 diabetes mellitus ( iNPHORM , United States)

Ratzki‐Leewing, A., Black, J. E., Kahkoska, A. R., Ryan, B. L., Zou, G., Klar, N., Timcevska, K., & Harris, S. B. (2023) · Diabetes, Obesity and Metabolism

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 24

Real-world incidence and risk factors for daytime and nocturnal non-severe hypoglycemia in adults with type 2 diabetes mellitus on insulin and/or secretagogues (InHypo-DM study, Canada)

Au, N. H., Ratzki-Leewing, A., Zou, G., Ryan, B. L., Webster-Bogaert, S., Reichert, S. M., Brown, J. B., & Harris, S. B. (2022) · Canadian Journal of Diabetes

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 14